We define Market Access as those interrelated activities necessary to create a favourable environment for the successful launch or further development of an asset/intervention.
In order to maximise the opportunity, Market Access needs to be considered as early as possible in development pathway - for example.
Roboleo & Co help their clients at any step along the pathway with a process of systematic analysis, creative input and rigorous testing - to create a clear, differentiated and compelling proposition supported by evidence and endorsed by stakeholders.
Our areas of expertise can be broadly classified under four headings:
Our clients, which include multinationals, SMEs and university spin-outs, come from a range of healthcare market sectors:
- Pharmaceuticals - Primary and Speciality Care
- Medical Devices - Consumables/Disposables and Equipment
- Diagnostics - Point-of-Care, Imaging and Laboratory services
- Consumer Healthcare
Our therapeutic category experience includes: Allergy, Analgesia/Pain management, Anti-infectives, Anti-fungals, Arthritis, Cardiovascular/circulatory diseases, Diabetes, Dermatology, Respiratory, Gastro-intestinal diseases, Neurology, Oncology, Smoking Cessation and Women’s Health.